Month: January 2021

Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, join Sana Board of Directors SEATTLE — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, have been appointed to the Sana Board of Directors. “Josh, Alise, and […]

SEATTLE — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Ke Liu, M.D., Ph.D., has joined the senior leadership team as Sana’s Head of Regulatory Affairs & Strategy. Dr. Liu joins Sana after more than 17 years at the U.S. Food and Drug Administration (FDA). Dr. Liu most […]